PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
10% Owner · Orchestra BioMed Holdings, Inc.
Every open-market stock purchase PERCEPTIVE LIFE SCIENCES MASTER FUND LTD has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.
Where the buys stand today
- ACRV−79.2% vs price paidAcrivon Therapeutics, Inc.
One purchase totalling $20.0M at an average of $8.50 per share; the stock last traded at $1.77. See all insider buying in ACRV →
Avg price paid$8.50Latest price$1.77Market cap$76.2M - OBIOOrchestra BioMed Holdings, Inc.
One purchase totalling $1.9M at an average of $2.75 per share. See all insider buying in OBIO →
Avg price paid$2.75Latest price—Market capUnknown - ALDX−40.7% vs price paidAldeyra Therapeutics, Inc.
2 purchases totalling $1.9M at an average of $3.85 per share; the stock last traded at $2.28. See all insider buying in ALDX →
Avg price paid$3.85Latest price$2.28Market cap$137.5M
Cluster participation
Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.
All reported buys
Follow new qualifying clusters involving PERCEPTIVE LIFE SCIENCES MASTER FUND LTD or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from PERCEPTIVE LIFE SCIENCES MASTER FUND LTD's Form 4 filings on SEC EDGAR (CIK 1249675) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.